|
1. |
Critical Pathways in Cardiology:A Journal of Evidence‐Based MedicineTranslating Evidence Into Practice |
|
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine,
Volume 1,
Issue 1,
2002,
Page 1-2
Christopher Cannon,
Preview
|
|
ISSN:1535-282X
出版商:OVID
年代:2002
数据来源: OVID
|
2. |
Management of Atrial Fibrillation |
|
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine,
Volume 1,
Issue 1,
2002,
Page 3-11
Leonard Ganz,
Preview
|
PDF (100KB)
|
|
ISSN:1535-282X
出版商:OVID
年代:2002
数据来源: OVID
|
3. |
Critical Pathway for Unstable Angina and Non‐ST Elevation Myocardial InfarctionFebruary 2002 |
|
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine,
Volume 1,
Issue 1,
2002,
Page 12-21
Christopher Cannon,
Preview
|
PDF (492KB)
|
|
ISSN:1535-282X
出版商:OVID
年代:2002
数据来源: OVID
|
4. |
Assessment of Compliance With the American College of Cardiology/American Heart Association Guidelines for Patients With Acute Coronary Syndromes Admitted to a Tertiary Care Hospital Coronary Care Unit |
|
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine,
Volume 1,
Issue 1,
2002,
Page 22-25
Marina Sharayeva,
James Tcheng,
Christopher Cannon,
Preview
|
PDF (1111KB)
|
|
ISSN:1535-282X
出版商:OVID
年代:2002
数据来源: OVID
|
5. |
Venous Thromboembolism Guidebook |
|
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine,
Volume 1,
Issue 1,
2002,
Page 26-43
Eli Gelfand,
Gregory Piazza,
Samuel Goldhaber,
Preview
|
PDF (158KB)
|
|
摘要:
&NA;This venous thromboembolism guidebook incorporates evolving contemporary concepts in diagnosis and management of pulmonary embolism (PE) and deep venous thrombosis (DVT) into a user‐friendly menu. The purpose of this document is to provide a literature‐based review of the current clinical approach to venous thromboembolism and up‐to‐date references for further study in this important topic.
ISSN:1535-282X
出版商:OVID
年代:2002
数据来源: OVID
|
6. |
Underutilization of Evidence‐Based Medications in Acute ST Elevation Myocardial InfarctionResults of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry |
|
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine,
Volume 1,
Issue 1,
2002,
Page 44-52
Christopher Cannon,
Maria Bahit,
Mark Haugland,
Timothy Henry,
Marc Schweiger,
George McKendall,
Prediman Shah,
Sabina Murphy,
Michael Gibson,
Carolyn McCabe,
Elliott Antman,
Eugene Braunwald,
Preview
|
PDF (1069KB)
|
|
摘要:
&NA;The TIMI 9 Registry set out to assess the management strategies and outcomes of an unselected group of patients with acute myocardial infarction presenting with ST segment elevation (STEMI). Demographic, procedural, and outcome data were collected from 840 consecutive patients with STEMI at 20 hospitals in United States and Canada between February and September 1994. Of them, 60% were treated with thrombolytic therapy, 9% with primary angioplasty, and 31% did not receive reperfusion therapy. Patients who did not receive reperfusion therapy were older, more likely female, and had a higher prevalence of prior myocardial infarction, congestive heart failure, higher Killip class on admission, and longer time from onset of symptoms to presentation. In evaluating the standard contraindications for fibrinolysis, approximately 10% in the thrombolytic group, 40% in the primary percutaneous coronary intervention (PCI), and 34% of those not receiving reperfusion therapy had at least one of these characteristics. Of those patients treated with fibrinolysis, only 20% met the National Heart Attack Alert Program goal of door‐to‐drug time <=30 minutes. Likewise, of those treated with primary PCI, only 30% had PCI performed within <=90 minutes. In‐hospital mortality was significantly higher for patients not treated with reperfusion therapy (18.9%), compared with patients treated with fibrinolysis (7.6%) and those treated with primary PCI (10.5%) (P < 0.001). Thus, we found that reperfusion therapy was underused, with only 69% of patients with STEMI receiving this proven treatment, and of those only 25% treated within the recommended timeline. These data suggest that there is room for improvement in the management of these patients.
ISSN:1535-282X
出版商:OVID
年代:2002
数据来源: OVID
|
7. |
How to Develop a Critical PathwayThe Acute Coronary Syndromes: Acute Cardiac Team to Implement Optimal Treatments Now (ACS ACTION) Program |
|
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine,
Volume 1,
Issue 1,
2002,
Page 53-60
Christopher Cannon,
Joseph Ornato,
Preview
|
PDF (846KB)
|
|
ISSN:1535-282X
出版商:OVID
年代:2002
数据来源: OVID
|
8. |
“Act in Time to Heart Attack Signs” Action PlanA Patient‐Based Critical Pathway |
|
Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine,
Volume 1,
Issue 1,
2002,
Page 61-65
Mary Hand,
Preview
|
PDF (1224KB)
|
|
摘要:
&NA;“Act in Time to Heart Attack Signs” provides various educational materials for health care providers, heart attack patients, and the public. These include a booklet, an educational video, and new Web pages, which can be reached through the National Heart, Lung, and Blood Institute website:http://www.nhlbi.nih.gov/actintime.
ISSN:1535-282X
出版商:OVID
年代:2002
数据来源: OVID
|
|